These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6432703)

  • 1. In vitro and in vivo effect of immunoglobulin G on the integrity of bacterial membranes.
    Dalhoff A
    Infection; 1984; 12(3):214-22. PubMed ID: 6432703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effect of immunoglobulin G on the integrity of bacterial membranes.
    Dalhoff A
    Infection; 1985; 13 Suppl 2():S185-93. PubMed ID: 3932218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria.
    Livermore DM
    Rev Infect Dis; 1988; 10(4):691-8. PubMed ID: 3142011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between acylureidopenicillins and immunoglobulin G in experimental animals.
    Dalhoff A
    Am J Med; 1984 Mar; 76(3A):91-100. PubMed ID: 6424463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect evidence of cell wall alterations in Pseudomonas aeruginosa by immunoglobulin preparations.
    Stübner G
    Infection; 1984; 12(3):223-4. PubMed ID: 6205998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.
    Hancock RE; Woodruff WA
    Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relations of 5,6-cis carbapenem antibiotics and role of factors determining susceptibility of Escherichia coli to beta-lactam antibiotics.
    Nozaki Y; Harada S; Kitano K; Imada A
    J Antibiot (Tokyo); 1984 Mar; 37(3):218-26. PubMed ID: 6373699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Soto UL; Amador SM; Ramos FJ; Baca BE
    Folia Microbiol (Praha); 1987; 32(4):290-6. PubMed ID: 3117650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the outer membrane permeability of bacteria].
    Nakae T
    Nihon Saikingaku Zasshi; 1990 Jul; 45(4):777-84. PubMed ID: 2122042
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
    Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
    J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.